A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results